Immunovia AB Stock London S.E.
Stocks
0G8X
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
London S.E.
10:45:34 2025-11-03 am EST
|
After hours 11:25:00 am | |||
| 31.92 SEK | -32.03% |
|
0.0620 | -99.81% |
| Oct. 05 | 23 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| Oct. 05 | Immunovia no longer has any public short sellers | FW |
| Market Cap | 47.83M 4.79M 4.26M 3.98M 3.61M 6.82M 462M 6.87M 18.6M 236M 17.99M 17.61M 758M | P/E 2026 * |
-0.71x | P/E 2027 * | -1.78x |
|---|---|---|---|---|---|
| Enterprise Value | 12.83M 1.29M 1.14M 1.07M 968K 1.83M 124M 1.84M 4.99M 63.22M 4.83M 4.72M 203M | EV / Sales 2026 * |
4.01x | EV / Sales 2027 * | 1.03x |
| Free-Float |
90.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Immunovia AB
| 1 day | -32.03% | ||
| 1 week | +20,654.23% | ||
| Current month | +32,638.46% | ||
| 1 month | +24,682.61% | ||
| 3 months | +16,370.59% | ||
| 6 months | +17,042.86% | ||
| Current year | +13,658.62% |
| 1 month | 0.1 |  | 0.32 |
| Current year | 0.1 | | 0.32 |
| 1 year | 0.1 | | 0.35 |
| 3 years | 0.1 | | 2.78 |
| 5 years | 0.1 | | 131.5 |
| 10 years | 0.1 | | 292 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 2023-04-28 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 2024-04-28 |
| Chief Tech/Sci/R&D Officer | 54 | 2024-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2016-12-08 | |
Peter Andersen
CHM | Chairman | 70 | 2023-05-25 |
| Director/Board Member | 51 | 2020-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -32.03% | +20,654.23% | - | - | 4.76M | |
| -2.98% | -3.39% | +20.71% | +31.70% | 250B | |
| -2.53% | -4.64% | +1.84% | -0.75% | 156B | |
| -0.42% | -1.80% | -9.99% | +36.89% | 144B | |
| -0.50% | -3.85% | -56.37% | -19.05% | 61.45B | |
| -0.86% | -1.82% | +12.96% | +17.34% | 50.28B | |
| +1.66% | -1.55% | -20.09% | -20.26% | 46.73B | |
| -1.00% | -3.26% | +19.57% | +53.05% | 48.29B | |
| +0.02% | +1.77% | -5.42% | +35.26% | 45.89B | |
| -0.84% | -1.54% | +33.21% | +63.21% | 43.24B | |
| Average | -3.72% | -2.32% | -0.40% | +21.93% | 93.91B | |
| Weighted average by Cap. | -1.23% | -2.77% | +2.86% | +22.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 321K 285K 266K 241K 456K 30.92M 459K 1.24M 15.77M 1.2M 1.18M 50.7M | 17.3M 1.73M 1.54M 1.44M 1.31M 2.47M 167M 2.48M 6.73M 85.27M 6.51M 6.37M 274M |
| Net income | -87M -8.72M -7.74M -7.24M -6.57M -12.4M -841M -12.49M -33.84M -429M -32.73M -32.03M -1.38B | -76M -7.62M -6.76M -6.33M -5.74M -10.83M -734M -10.91M -29.56M -375M -28.59M -27.98M -1.2B |
| Net Debt | -35M -3.51M -3.11M -2.91M -2.64M -4.99M -338M -5.02M -13.61M -173M -13.17M -12.89M -555M | -30M -3.01M -2.67M -2.5M -2.26M -4.28M -290M -4.31M -11.67M -148M -11.29M -11.04M -475M |
Employees
18
Calendar
Nov. 04
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
- 0G8X Stock
Select your edition
All financial news and data tailored to specific country editions
